At the end of the year, MNC set off a wave of layoffs involving Novartis, Sanofi, Eli Lilly...

According to overseas news, Takeda announced on December 21st that it had reached an agreement with Heisman Biopharmaceutical Co., Ltd. to spin off some of its prescription drug business in Chinese mainland to Heisman Biopharmaceuticals.
it is understood that the business areas to be divested are cardiovascular and metabolic, the main products include Biros, Yaningding, Akoto, Pershing.
learned that Takeda's cardiovascular business has not been smooth in the recent development, especially by the impact of domestic volume procurement policy, some pharmaceutical market share is not high.
nearly two years, Takeda has focused its core business areas on five focus areas: digestion, rare diseases, blood products, oncology and neuroscience.
, it is clear that cardiovascular and metabolic services are no longer the focus.
addition to Takeda, Pfizer and Novaral were also affected.
Pfizer spun off its cardiovascular product line to Proms and merged with Mylan; Novarma's cardiovascular product line has been merging this year.
2020 is coming to an end, a year in which three batches of state-to-state executions, followed by the fourth batch, and the high-profile health-care negotiations ended last week. Under these series of pharmaceutical policies, small enterprises are caught in the middle of life, multinational pharmaceutical companies are even bitter, enterprises can only according to their own products under the new policy of the future market expectations of the corresponding market adjustment. in the two months to the end of
, in addition to some of Takeda's business adjustments, there are still a number of multinational pharmaceutical companies are also making internal restructuring adjustments and even layoffs.
Roche will make internal adjustments to guangdong and Sichuan and Chongqing regions as a pilot, the establishment of a regional model.
the regional model would decentralize more autonomy and break with the existing product line sales model.
pilot area will become two zones responsible for the marketing, sales, medical, regional access and related business functions of all products in their area except lymphoma and rare diseases.
said Roche would launch a competitive induction system in both zones, replacing the hierarchical relationship of "director-region-region-representative" with a "regional head-circle-representative" model.
, all positions need to be re-hired, regional and regional competition ring leader, representatives are competing for first-line positions.
Novarics has adjusted its product line since December 1st: the Cardiovascular Division and the Basic Diseases Division have been merged into the new Cardiovascular, Kidney and Metabolic Division, and the Transplant and Respiratory Division has been established by the Integrated Transplant and Respiratory Two Agents team.
regard to the compensation scheme, it is not clear whether the movement of persons due to product line adjustments is compensated, some people say it is N3, and some people say Novart has never paid compensation.
AstraZeneca AstraZeneca announced the restructuring on December 3rd, with the following major architectural changes: "Andatang Cardiovascular Metabolism and Kidney Business will work together to promote the CVM team will continue to be responsible for endocrinology, intra-heart and other departments in hospitals already covered by the Roxa team for the kidney business, and the Roxa team will be responsible for the promotion and maintenance of nephrology;
Arijo CM team will be responsible for the five counties of Ari Zhuodongbusiness (Shandong, Jiangsu, Zhejiang, Fujian, Guangdong), with the help of CVM in the east five advantages and characteristics of promotion;
Sanofi on November 25, sanofi employees broke the news that they received internal mail requests to go to Hangzhou/Guangzhou on the same day, the second day of the interview.
it is understood that received this email for the Cardiovascular and Mature Products Division, the product group of low-performing employees, no matter the length of time in the company, there are product groups from representatives, regions to regions, all in the layoff list.
compensation scheme for Sanofi's layoff is to sign a compensation agreement on the 26th, in accordance with the "N-3" way of compensation.
after the signing, or did not come and sign, according to the "N1" method of settlement.
working hours are 31 December.
Lilly has been recognized as a "pension" pharmaceutical company.
on November 10th, it was reported in the media that Lilly was adjusting its product line.
other words, Lilly has made a wave of layoffs involving the following positions: Central Nervous Product Line, Bone Pine Product Line, and XAL Products Hospital Team.
is understood that Lilly canceled the above three product line teams, after the product line staff partly transferred to the tumor product line, part to the insulin product line.
its compensation scheme is "N-1".
announced earlier this year that it would spin off women's health, traditional brands and biosimilar products to form a new independent public company.
and the resulting split also triggered a wave of personnel changes.
Some of the original company's product line employees signed the new company program as follows: " Received a new "labor agreement" signed on the same day, on-site to or sent to the relevant staff of the staff, you can get a three-month basic salary reward, the payment date is divided into two, the first for June 2021, with the salary of 1 month, the second for December 2021, with the wages of 2 months; Receive a new Labor Agreement signed and sent to the relevant staff within 3 days, receive a one-month basic salary award, pay date of December 2021, with pay;
two days ago, there were media reports that Viatris Inc. was planning to lay off workers.
, according to known sources, the planned layoffs come from the pain field.
that 20 per cent of the anti-infection product line representatives in an area would be cut.
previously, there had been internal adjustments in the CV plus pain area.
the current adjustment and bidding in some regions has only just begun.
this month, a regional competition began, according to the position, level and so on.
first is the regional manager bid, followed by the DM bid, and finally the representative bid.
that the laid-off workers may be the failed bid representatives.
he was paid five times his base salary for a layoff with a shorter working life.
understand that corporate emails include the number of years of service, base salary and compensation amount of the laid-off representatives.
the amount of compensation is calculated, the e-mail does not specify the policy of downsizing, nor is it possible to know how this amount is calculated.
。